WCN26-1844 Characterization of regulatory B cells and IL-10 in response to ischemic reperfusion and potential for novel therapy

Read full text Summarise with VIRAT
Authors: Yuya Yamashita, Kensei Taguchi, Yunosuke Yokota, Kei Fukami
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Acute kidney injury (AKI) occurs in approximately 15% of hospitalized patients and it predisposes the patients to chronic kidney disease (CKD). Interleukin-10 (IL-10) is a pleiotropic cytokine, and exogenous IL-10 replacement therapy is renoprotective effect against AKI. However, the required concentration of IL-10 seems not feasible to achieve when applied to human. Subpopulation of B cells presenting with CD1dhiCD5+ (regulatory B cells; Breg) are known to be responsible for producing and secreting IL-10.

Fields of Study & Subjects

Acute Kidney Injury Research T-cell and B-cell Immunology Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103868–103868
Publication date
25 March 2026
Language
EN